Skip to main content
logo
GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
75.82
+4.71 (6.62%)
At close: Oct 28, 2026, 4:00 PM EDT
76.46
+0.64 (0.84%)
After-hours: Oct 28, 2026, 7:59 PM EDT

GEHC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
-5,2945,1315,698-5,0064,7775,3194,8634,8394,6505,2064,8224,8174,7074,9384,5764,4844,3434,589
Other Revenue
-1---1--------------
Revenue
-5,2955,1315,698-5,0074,7775,3194,8634,8394,6505,2064,8224,8174,7074,9384,5764,4844,3434,589
Revenue Growth (YoY)
-5.75%7.41%7.12%-3.47%2.73%2.17%0.85%0.46%-1.21%5.43%5.38%7.43%8.38%7.61%6.30%3.17%-0.07%-
Cost of Revenue
-3,1153,1543,437-3,0232,7653,0442,8382,8372,7493,0502,8872,8772,8163,0062,8032,6882,6652,727
Gross Profit
-2,1801,9772,261-1,9842,0122,2752,0252,0021,9012,1561,9351,9401,8911,9321,7731,7961,6781,862
Selling, General & Admin
-1,0641,0631,042-9559621,0269289629331,133878950945945906906929911
Research & Development
-323345323-302344344316327324315322298270271260257238225
Operating Expenses
-1,3871,4081,365-1,2571,3061,3701,2441,2891,2571,4481,2001,2481,2151,2161,1661,1631,1671,136
Operating Income
-793569896-727706905781713644708735692676716607633511726
Interest Expense
--133-115-6--124-122-37-141-141-148-68-147-145-145-60-2-22-6-6
Interest & Investment Income
-7-24-6--5--76-13-4--6
Earnings From Equity Investments
---3--1332212-54136310
Currency Exchange Gain (Loss)
-1918-97-1011-74111010-64101210-----
Other Non Operating Income (Expenses)
-7364--6-238-1-6524156-12-410222519
EBT Excluding Unusual Items
-693505821-614596835657578512609619570546653622639533755
Gain (Loss) on Sale of Investments
------97-------------
Other Unusual Items
------1-1-1----17--65----
Pretax Income
-693505821-613692834657578512609636570546718622639533755
Income Tax Expense
-11994219-11310496168143124193250137163151129153131179
Earnings From Continuing Operations
-574411602-500588738489435388416386433383567493486402576
Earnings From Discontinued Operations
-------------4--6-12--
Net Income to Company
-574411602-500588738489435388416382433383573493498402576
Minority Interest in Earnings
--13-22-13--14-24-17-19-7-14-13-7-15-194-19-6-13-13-12
Net Income
-561389589-486564721470428374403375418189554487485389564
Net Income to Common
-561389589-486564721470428374403375418189554487485389564
Net Income Growth (YoY)
-15.43%-31.03%-18.31%-13.55%50.80%78.91%25.33%2.39%97.88%-27.26%-23.00%-13.81%-51.41%-1.77%-5.25%-17.02%-33.45%-
Shares Outstanding (Basic)
452453456456456457457457457457456455455455454454454454454-
Shares Outstanding (Diluted)
453454457457457458459459459459459458458458457454454454454-
Shares Change (YoY)
-0.88%-0.87%-0.44%-0.44%-0.44%-0.22%-0.22%0.22%0.22%0.44%0.88%0.88%0.88%0.66%-----
EPS (Basic)
1.361.240.851.290.981.061.231.581.030.940.820.890.820.920.421.221.071.070.86-
EPS (Diluted)
1.361.240.851.290.981.061.231.571.020.930.810.880.820.910.411.221.071.070.86-
EPS Growth (YoY)
39.05%16.83%-30.89%-17.73%-4.11%13.98%51.85%78.41%24.20%2.20%97.56%-27.88%-23.25%-14.67%-52.15%-----

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
79368112916483898811--183274956570-137325965548-368-83
Free Cash Flow Per Share
1.750.150.242.001.060.020.211.77--0.400.602.091.25-0.300.712.131.21-0.81-
Dividend Per Share
0.0400.0350.0350.0350.0350.0350.0350.0350.0300.0300.0300.0300.0300.0300.030-----
Dividend Growth (YoY)
14.29%0%0%0%16.67%16.67%16.67%16.67%0%0%0%---------
Gross Margin
40.18%41.17%38.53%39.68%38.67%39.62%42.12%42.77%41.64%41.37%40.88%41.41%40.13%40.27%40.17%39.13%38.75%40.05%38.64%40.58%
Operating Margin
-14.98%11.09%15.72%-14.52%14.78%17.01%16.06%14.73%13.85%13.60%15.24%14.37%14.36%14.50%13.26%14.12%11.77%15.82%
Profit Margin
-10.60%7.58%10.34%-9.71%11.81%13.55%9.66%8.85%8.04%7.74%7.78%8.68%4.01%11.22%10.64%10.82%8.96%12.29%
Free Cash Flow Margin
-1.28%2.18%16.08%-0.16%2.05%15.25%--3.78%5.89%18.36%11.82%-2.84%6.91%19.54%11.98%-8.47%-1.81%
EBITDA
-9537221,042-8758421,045924862792852888848833873767790670880
EBITDA Margin
18.36%18.00%14.07%18.29%17.09%17.48%17.63%19.65%19.00%17.81%17.03%16.37%18.42%17.60%17.70%17.68%16.76%17.62%15.43%19.18%
D&A For EBITDA
163160153146148148136140143149148144153156157157160157159154
EBIT
-793569896-727706905781713644708735692676716607633511726
EBIT Margin
15.40%14.98%11.09%15.72%14.21%14.52%14.78%17.01%16.06%14.73%13.85%13.60%15.24%14.37%14.36%14.50%13.26%14.12%11.77%15.82%
Effective Tax Rate
17.13%17.17%18.61%26.67%27.84%18.43%15.03%11.51%25.57%24.74%24.22%31.69%39.31%24.04%29.85%21.03%20.74%23.94%24.58%23.71%
Revenue as Reported
-5,2955,1315,698-5,0074,7775,3194,8634,8394,6505,2064,8224,8174,7074,9384,5764,4844,3434,589
SEC Filings: 10-K · 10-Q